# Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study

> **NCT02612376** · — · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 800 (estimated)

## Conditions studied

- Alzheimer Disease
- Down Syndrome
- Mild Cognitive Impairment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02612376
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2025-04
- **Final completion:** 2025-05
- **Target enrollment:** 800 (ESTIMATED)
- **Why stopped:** Loss of funding
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02612376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02612376, "Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02612376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*